Stay updated with breaking news from Phase Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProPhase Labs (NASDAQ:PRPH) CEO Ted Karkus joins Natalie Stoberman in the Proactive studio to break down how the company has transformed in the biotech...
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. - read this article along with other careers information, tips and advice on BioSpace
GARDEN CITY, NY, Oct. 17, 2022 -- ProPhase Labs, Inc. , a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, Nebula... | October 17, 2022
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $9.77 and traded as high as $10.68. ProPhase Labs shares last traded at $10.26, with a volume of 51,993 shares. Analysts Set New Price Targets A number […]
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...